Chemotherapy-induced myelosuppression.

[1]  M. Kris,et al.  Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer , 1991 .

[2]  J. Armitage,et al.  Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer. , 1991, The New England journal of medicine.

[3]  R. McCorkle,et al.  Cancer Nursing: A Comprehensive Textbook , 1991 .

[4]  P. Jassak,et al.  A teaching booklet for patients receiving GM-CSF therapy. , 1991, Oncology nursing forum.

[5]  D. Haeuber.  Future strategies in the control of myelosuppression: the use of colony-stimulating factors. , 1991, Oncology nursing forum.

[6]  J. DiJulio.  Hematopoiesis: an overview. , 1991, Oncology nursing forum.

[7]  D. Metcalf.  The colony stimulating factors discovery, development, and clinical applications , 1990, Cancer.

[8]  J. Pavel.  Red blood cell transfusions for anemia. , 1990, Seminars in oncology nursing.

[9]  J. Collingwood,et al.  Physiology of blood and bone marrow. , 1990, Seminars in oncology nursing.

[10]  D. Longo,et al.  Recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy: a phase Ib trial. , 1990, Journal of the National Cancer Institute.

[11]  K. Hays.  Physiology of normal bone marrow. , 1990, Seminars in oncology nursing.

[12]  Glaspy Ja,et al.  The promise of colony-stimulating factors in clinical practice. , 1990 .

[13]  M. Frank-Stromborg.  Nursing protocol for the patient with neutropenia. , 1990 .

[14]  Rostad Me.  Management of myelosuppression in the patient with cancer. , 1990 .

[15]  F. Appelbaum.  The clinical use of hematopoietic growth factors. , 1989, Seminars in hematology.

[16]  M. Goodman.  Managing the side effects of chemotherapy. , 1989, Seminars in oncology nursing.

[17]  Bar Mh,et al.  Recombinant human GM-CSF in myelosuppression of chemotherapy (continued) , 1989 .

[18]  D. Haeuber,et al.  Hemopoietic colony stimulating factors: an overview. , 1989, Oncology nursing forum.

[19]  F. Herrmann,et al.  Hematopoietic responses in patients with advanced malignancy treated with recombinant human granulocyte-macrophage colony-stimulating factor. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  W. Piacibello,et al.  Kinetics of human hemopoietic cells after in vivo administration of granulocyte-macrophage colony-stimulating factor. , 1989, The Journal of clinical investigation.

[21]  J. Griffin.  Hemopoietins in oncology: factoring out myelosuppression. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  J. Singer,et al.  Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies. , 1988, Blood.

[23]  R. Bast,et al.  Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. , 1988, The New England journal of medicine.

[24]  R. Kamen,et al.  The human hematopoietic colony-stimulating factors. , 1987, Science.

[25]  J. Lilleyman,et al.  The effect of folate supplements on 6-mercaptopurine remission maintenance therapy in childhood leukaemia. , 1986, British Journal of Cancer.

[26]  R. Schofield.  Assessment of cytotoxic injury to bone marrow. , 1986, The British journal of cancer. Supplement.

[27]  Koza Cm.  Principles and practices of cancer chemotherapy. , 1983 .

[28]  H. Hoagland.  Hematologic complications of cancer chemotherapy. , 1982, Seminars in oncology.